On November 25, 2019, CymaBay halted all clinical trials of seladelpar after atypical histologic findings with no clinical or laboratory correlates were identified at the
July 30, 2020
No Comments
Blog
Author: jim@snap-metrics.com
- Home
- Author: jim@snap-metrics.com
PBC News
This year the PBC Network created a 36 page booklet “PBC – Living With Your Diagnosis” . The Canadian PBC Society participated in the final
January 9, 2020
No Comments
Seladelpar, a drug developed for PBC patients, has shown positive results in Phase 2 studies- normalizing ALP levels, while not associated with itching. In
November 25, 2019
No Comments
Clinical Trials
Elafibranor, phase 2 trial has shown positive preliminary results in helping those PBC patients who do not respond to UDCA (Urso). In addition, Elafibranor has
November 8, 2019
No Comments
PBC News
University of Calgary PBC researchers tested the anti-depressant mirtazapine on mice and found promising results. Their report concluded that mirtazapine may represent a novel therapeutic
November 7, 2019
No Comments
Clinical Trials
PBC patients across Canada can get involved in a number of Clinical Trials. Learn more about all of the clinical trials now underway and read
September 24, 2019
No Comments
Clinical Trials
Linerixibat (GSK2330672), a drug that is being developed for PBC patients who experience itchiness, has recently been granted “orphan” status by the FDA. This is
September 24, 2019
No Comments
Clinical Trials
As a result of extremely promising results of Phase 2 trials, Cymabay Therapeutics is now enrolling patients in a Phase 3 study for Seladelpar. This
September 23, 2019
No Comments
PBC News
Read the results of our patient survey which was initiated in 2015, with more than 250 PBC patients reporting how PBC affects their daily lives.
April 4, 2019
No Comments
Clinical Trials
Genkyotex “published interim efficacy results today, GKT831 met both it’s primary and secondary endpoints in the Phase II PBC trial! A big thank you to the
November 6, 2018
No Comments